HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer
Details
Publication Year 2023-04,Volume 30,Issue #4,Page 629-640
Journal Title
Cancer Gene Therapy
Publication Type
Research article
Abstract
Integration of high-dimensional tumor gene expression data with clinicopathological data can increase our understanding of disease diversity, enable retrospective patient stratification, and identify new potential biomarkers and therapeutic targets. Using a systems biology approach, we provide a holistic overview of gene co-expression networks in head and neck squamous cell carcinomas (HNSCC). Weighted gene co-expression network analysis of HNSCC RNA sequencing data from 519 patients from The Cancer Genome Atlas (TCGA) was used to determine correlates of 5-year survival, using regression tree-based optimal threshold calculations. Survival-associated gene sets were transformed to gene set scores that were assessed for correlation with clinicopathological data. We identified 8 gene co-expression modules for HNSCC tumors, each of which contained co-expressed genes associated significantly with 5-year survival. Survival-associated co-expression gene signatures correlated dominantly with tumor HPV and p16 status. Network analysis identified that survival was associated with signaling networks of infection, immunity, epithelial-mesenchymal transition (EMT), hypoxia, glycolysis, focal adhesion, extracellular matrix, MYC signaling, autophagy and transcriptional regulation. EMT-associated gene signatures were expressed dominantly in fibroblasts, and cancer-associated fibroblasts were inversely correlated with immune activity. Interestingly, a high Immune Suppression Score based on expression of 21 genes associated with immune inhibition and including immune checkpoints, cytokines and regulatory T cell factors, was also associated with increased survival probability, and was significantly higher in HPV+ HNSCC. Networks associated with HNSCC survival were further associated with survival in cervical cancer, melanoma and lung cancer. This study defines 5129 genes associated with HNSCC survival, organized into co-expressed networks, their correlation with clinicopathological data, and with gene expression data from other malignant diseases, and provides a source for the discovery of biomarkers and novel therapies for HNSCC.
Publisher
Springer Nature
Keywords
Humans; Squamous Cell Carcinoma of Head and Neck/genetics; *Papillomavirus Infections/complications/genetics; Proto-Oncogene Proteins c-myc; Retrospective Studies; Signal Transduction; *Head and Neck Neoplasms/genetics; Gene Expression Regulation, Neoplastic; Biomarkers; Prognosis; Biomarkers, Tumor/genetics
Department(s)
Radiation Oncology
PubMed ID
36575316
Open Access at Publisher's Site
https://doi.org/10.1038/s41417-022-00577-9
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-08-03 07:58:23
Last Modified: 2023-08-03 08:01:33

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙